Their lead program, AEB1102, aims to lower elevated arginine within the blood as enzyme substitute therapy for Arginase 1 deficiency and treatment of arginine-dependent tumors. With an amino acids manufacturer for pharmaceuticals acid volume share of 56.8% in the food and dietary supplements software in 2022, it is predicted to continue to steer the market o...
1 monthДома или квартиры в аренду23846 - Piazza Pilastri 13020 views